---
theme: academic
layout: cover
class: text-white
coverAuthor: beau hilton
coverAuthorUrl: https://www.beauhilton.com
coverDate: "2023-12-15"
themeConfig:
  paginationX: r
  paginationY: t
  paginationPagesDisabled: [1]
title: Primary Mediastinal B-Cell Lymphoma
info: |
  # Primary Mediastinal B-Cell Lymphoma
  Case Conference 2023-12-15, [Beau Hilton](https://www.beauhilton.com)
---

# Primary Mediastinal B-Cell Lymphoma

---

# Presentation

35M, athlete, no known medical problems.

<v-clicks>

<p class="text-xs">(all dates modified for HIPAA, relative time spans preserved for instruction)</p>

2023-04-15: Working in the crawl space under his house, developed progressive and eventually severe L arm pain and swelling.

Went to local ED: LUE DVT, put on rivaroxaban. CTPE: +supraclav LN, o/p f/u recommended.

2023-04-20: Called 911 for dyspnea.

2023-04-21: OSH obtained cervical LN core bx: paracortical hyperplasia w focal necrosis

2023-05-05: OSH ER for f/ns and arthralgia, given amox x5d

2023-05-10: Our ER for f/c/ns/n/v, weight loss, chest pain, HA, pruritus.

CT chest: +mediastinal mass, SVC compression w/o critical stenosis, R pleural effusion

</v-clicks>

---

# CT

<!-- If I was smart I would write a Vue component to make interactive imaging.
     It would be really nice to take in a folder of images,
     rather than a manually typed list of discrete links.
     But this works:
     bastardized list css and layered jpgs.
-->

<style>
li{
    position:absolute;
    top:30;
    left:100;
    list-style-type: none;
}
</style>

<v-clicks class="fixed top-0 left-50 right-0">

- ![img](/images/ct-06.jpg)
- ![img](/images/ct-14.jpg)
- ![img](/images/ct-23.jpg)
- ![img](/images/ct-33.jpg)
- ![img](/images/ct-41.jpg)
- ![img](/images/ct-49.jpg)
- ![img](/images/ct-57.jpg)
- ![img](/images/ct-66.jpg)
- ![img](/images/ct-74.jpg)
- ![img](/images/ct-82.jpg)
- ![img](/images/ct-93.jpg)

</v-clicks>

<div class="-translate-x-11 translate-y-105"><a class="text-xs">https://radiopaedia.org/cases/8655</a></div>

---

# Presentation continued

<v-clicks>

2023-05-15: core bx of mediastinal LN done

2023-05-16: feeling much better (fluids and other supportive care), d/c home

2023-05-17: bx resulted as large B-cell neoplasm.
Primary team notified him,
he was doing ok and o/p f/u scheduled already for next week, so deferred readmission.


</v-clicks>

---

# Office visit and admission

<v-clicks>

2023-05-24: HR 130s, dyspneic, plethoric, but able to get around w/o assistance and speak in complete sentences.

Discussed DLBCL vs PMBCL, possibility of cure in either case, recommended admission for expedited w/u and tx start.

Contacted thoracic team for mediastinoscopy, which they accommodated same-day (+chest tube).

Mostly fibrotic tissue, "like chopping through wood".

Wrote for R-EPOCH to start next day.

(results came back a few days later: mostly fibrosis, crush artifact, necrosis

**mature B-cell markers**: CD20+, CD45+, PAX5+.

**PMBCL**: CD23 patchy ( -ve in DLBCL, cHL, MGZL),
CD30 patchy (30% DLBCL, but weak+ in most PMBCL),
CD10- (nonGC), equivocal [BCL2/6, c-MYC, MUM1],
EBER-

</v-clicks>

---

# Admission continued

<v-clicks>

- FDG-PET CT: 9.4x6.3cm mediastinal mass, LAD, diffuse axial skeleton uptake (hyperplasia vs infiltration)
- BMBx: NED
- SVC syndrome: much back and forth re SVC stent, RT.
    - Ultimately pursued neither, sx slowly improved.

</v-clicks>

---

# Subsequent cycles

<v-clicks>

- C2: dose level +0
    - (late onset severe neutropenia - ?GCSF)
- C3: dose level +1
- Interval FDG-PET CT: "near complete resolution" (tiny remnant FDG+, ?malignant vs reactive)
- C4: dose level +0 (late onset severe neutropenia)
- C5: dose level +1
- C6: dose level +2
- EOT FDG-PET: next week!

</v-clicks>

---

# Questions

- How common is it and who gets it?
- What is the typical presentation?
- What are the key parts of the workup?
- How common are nondiagnostic biopsies?
- What are the key parts of treatment?
- What is the role of radiotherapy?
- How should we approach post-treatment surveillance?
- What are the long-term adverse effects of surviving therapy?

---

# Epidemiology

- 2-4% of all NHL (SEER 2023 estimate 80,550 NHL * 2% = ~1600-3200/yr)<sup>1</sup>
- ~60% female<sup>2</sup>
- median age 30-35<sup>2,3</sup>

<Footnotes separator>
  <Footnote :number=1><a href="https://seer.cancer.gov/statfacts/html/nhl.html">SEER 2023</a></Footnote>
  <Footnote :number=2><a href="https://doi.org/10.1056/NEJMoa1214561">NEJM 2013</a></Footnote>
  <Footnote :number=3><a href="https://www.sciencedirect.com/science/article/pii/S2152265021002421">Clinical Lymphoma, Myeloma, and Leukemia 2021</a></Footnote>
</Footnotes>

---

# S/sx prevalence at presentation (~%)


<table class="tg">
<tbody>

<tr>
 <td> Tumor size &ge;10cm<sup>1</sup> </td>
 <td> 60 </td>
</tr>

<tr>
 <td> Clinical SVC syndrome<sup>1</sup> </td>
 <td> 55 </td>
</tr>

<tr>
 <td> Radiographic SVC compromise<sup>1</sup> </td>
 <td> 80 </td>
</tr>

<tr>
 <td> Pleural effusion<sup>2</sup> </td>
 <td> 50 </td>
</tr>

<tr>
 <td> VTE<sup>3</sup> </td>
 <td> 35 </td>
</tr>

<tr>
 <td> B symptoms<sup>4</sup> </td>
 <td> 30-50 </td>
</tr>

</tbody>
</table>

<Footnotes separator>
  <Footnote :number=1><a href="https://doi.org/10.1002/1097-0142(19881101)62:9%3C1893::aid-cncr2820620904%3E3.0.co;2-x">Cancer 1988</a></Footnote>
  <Footnote :number=2><a href="https://doi.org/10.1056/NEJMoa1214561">NEJM 2013</a></Footnote>
  <Footnote :number=3><a href="https://doi.org/10.1016/j.thromres.2010.08.017">Thrombosis Research 2010</a></Footnote>
  <Footnote :number=4><a href="https://doi.org/10.1093/annonc/mdj030">Annals of Oncology 2006</a></Footnote>
</Footnotes>

<!-- Cancer 1988 paper:
     Mass Gen 1976-1985,
     20F and 10M,
     median age 34,
     CHOP+RT = 80% CR, 60% PFS at 5y,
     tumor bulk predicted tx failure.

     Plenty of older papers correlated pleural effusion, VTE, and tumor bulk with worse outcomes,
     but the new treatments (DA-R-EPOCH) are so good that the old prognostic indicators are less important.
     Extent of extranodal disease still seems to matter (more predictive of CNS involvement, maybe relapse),
     but less than it used to.
-->

---

# Selected clinicopathological features (~%)


<table class="tg">
<tbody>


<tr>
 <td> Bone marrow involvement<sup>1</sup> </td>
 <td> 2 </td>
</tr>

<!-- No need for BMBx. -->
<!-- If you're having a hard time getting tissue from elsewhere -->
<!-- and the PET lights up in the marrow, would be reasonable to BMBx. -->
<!-- Al Shemmar 2014 reported 11% BMBx+ (and I've seen reviews cite this number since it's more recent), -->
<!-- but that was 3/28 pts, every other study that reports BMBx data shows low single digits. -->

<tr>
 <td> CNS involvement<sup>2</sup> </td>
 <td> 5-10 </td>
</tr>

<!-- Also no need for LP and IT Cx. -->
<!-- Most studies don't report out CNS involvement. -->
<!-- The higher end of the range seems to be related to extensive extranodal disease -->
<!-- (i.e. if there's not much extranodal disease, v unlikely to have CNS disease). -->
<!-- Relapsed disease also has a higher propensity for the CNS. -->
<!-- One reasonable approach would be to save LP and IT Cx for presentations w extensive extranodal disease, -->
<!-- CNS sx, and relapses. -->

<tr>
 <td> Marked fibrosis<sup>1</sup> </td>
 <td> 25 </td>
</tr>

<!-- Most samples have some fibrosis. -->
<!-- A significant amount have so much fibrosis that it's hard to make a diagnosis. -->
<!-- (as with cHL, difficulty in getting a tissue diagnosis is itself a clue) -->
<!-- Core bx are often not enough. -->
<!-- Mediastinoscopy or similarly invasive and comprehensive bx approaches are needed in many cases. -->
<!-- There are rare cases that do not have apparent disease in the mediastinum, -->
<!-- in which case you need a smart pathologist to run all the right IHC and genetic tests to get to an answer. -->
<!-- The fibrosis also suggests some of the difficulties -->
<!-- in interpreting PET-CT (and images in general): some residual scar tissue is common. -->

</tbody>
</table>

<Footnotes separator>
  <Footnote :number=1><a href="https://doi.org/10.1097/00000478-199607000-00012">Am J Surg Pathol 1996</a></Footnote>
  <Footnote :number=2><a href="https://doi.org/10.1200/jco.1999.17.8.2479">JCO 1999</a></Footnote>
</Footnotes>

<!-- Cancer 1988 paper:
     Mass Gen 1976-1985,
     20F and 10M,
     median age 34,
     CHOP+RT = 80% CR, 60% PFS at 5y,
     tumor bulk predicted tx failure.
-->

---

# Management

<div class="container mx-auto grid gap-4 grid-cols-2">
<div>
<img class="flex items-center w-100 h-75 hover:scale-130 hover:opacity-100" src="/images/cancer-1988-survival.png" />
<div class="text-xs text-center">Cancer 1988: CHOP21 + 40Gy RT. </div>
</div>
<div>
<img class="flex items-center w-100 h-75 hover:scale-130 hover:opacity-100" src="/images/pmbcl-da-r-epoch-survival.png" />
<div class="text-xs text-center">NEJM 2013: DA-R-EPOCH. </div>
</div>
</div>

---

# Management

<div class="container mx-auto grid gap-4 grid-cols-2">
<div>
<img class="flex items-center w-100 h-75 hover:scale-130 hover:opacity-100" src="/images/pmbcl-nejm-2013-os.png" />
<div class="text-xs text-center">NEJM 2013: DA-R-EPOCH. </div>
</div>
<div>
<img class="flex items-center w-100 h-75 hover:scale-130 hover:opacity-100" src="/images/rchop-vs-darepoch.png" />
<div class="text-xs text-center">BJH 2018: R-CHOP vs DA-R-EPOCH. </div>
</div>
</div>

---

# Monitoring

<div class="container mx-auto grid gap-4 grid-cols-2">
<div>
<img class="flex translate-x-1 h-75 hover:scale-130 hover:opacity-100" src="/images/pmbcl-pet-ppv.png" />
<div class="text-xs text-center">NEJM 2013: DA-R-EPOCH. </div>
</div>
<div>
<img class="flex translate-x-23 h-75 hover:scale-130 hover:opacity-100" src="/images/pmbcl-cardiotox.png" />
<div class="text-xs text-center">BJH 2018: R-CHOP vs DA-R-EPOCH. </div>
</div>
</div>

---

# Future directions

<v-clicks>

- PD-L1++
    - [KEYNOTE-170](https://doi.org/10.1182/blood.2022019340)
        - pembro monotherapy for R/R PMBCL
        - N=53, median LoT 3 (26.4% ASCT)
        - ORR 41.5%, CR 20.8%, mOS 22.3mo, 4y OS 45.3%
    - --> frontline chemo + pembro
        - [NCT04759586](https://clinicaltrials.gov/study/NCT04759586) (investigator's choice + pembro)

- Cellular therapy
    - e.g. [ZUMA-1](https://doi.org/10.1182/blood.2022018893)
        - axi-cel CAR-T
        - N=101, R/R LCL, 8% PMBCL
        - ORR 83%, CR 58%, mOS 25.8mo, 5y OS 42.6%

</v-clicks>


---

# Bibliography

<div class="csl-bib-body text-sm" style="line-height: 1.35; margin-left: 2em; text-indent:-2em;">
  <div class="csl-entry">Ahmed, Z., Afridi, S. S., Shahid, Z., Zamani, Z., Rehman, S., Aiman, W., Khan, M., Mir, M. A., Awan, F. T., Anwer, F., &amp; Iftikhar, R. (2021). Primary Mediastinal B-Cell Lymphoma: A 2021 Update on Genetics, Diagnosis, and Novel Therapeutics. <i>Clinical Lymphoma Myeloma and Leukemia</i>, <i>21</i>(11), e865–e875. <a href="https://doi.org/10.1016/j.clml.2021.06.012">https://doi.org/10.1016/j.clml.2021.06.012</a></div>
  <span class="Z3988" title="url_ver=Z39.88-2004&amp;ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fzotero.org%3A2&amp;rft_id=info%3Adoi%2F10.1016%2Fj.clml.2021.06.012&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Primary%20Mediastinal%20B-Cell%20Lymphoma%3A%20A%202021%20Update%20on%20Genetics%2C%20Diagnosis%2C%20and%20Novel%20Therapeutics&amp;rft.jtitle=Clinical%20Lymphoma%20Myeloma%20and%20Leukemia&amp;rft.stitle=Clinical%20Lymphoma%20Myeloma%20and%20Leukemia&amp;rft.volume=21&amp;rft.issue=11&amp;rft.aufirst=Zahoor&amp;rft.aulast=Ahmed&amp;rft.au=Zahoor%20Ahmed&amp;rft.au=Safa%20Saadat%20Afridi&amp;rft.au=Zeryab%20Shahid&amp;rft.au=Zarlakhta%20Zamani&amp;rft.au=Sana%20Rehman&amp;rft.au=Wajeeha%20Aiman&amp;rft.au=Maryam%20Khan&amp;rft.au=Muhammad%20Ayaz%20Mir&amp;rft.au=Farrukh%20T.%20Awan&amp;rft.au=Faiz%20Anwer&amp;rft.au=Raheel%20Iftikhar&amp;rft.date=2021-11-01&amp;rft.pages=e865-e875&amp;rft.spage=e865&amp;rft.epage=e875&amp;rft.issn=2152-2650"></span>
  <div class="csl-entry">Al Shemmari, S., Sankaranarayanan, S. P., &amp; Krishnan, Y. (2014). Primary mediastinal large B-cell lymphoma: Clinical features, prognostic factors and survival with RCHOP in Arab patients in the PET scan era. <i>Lung India : Official Organ of Indian Chest Society</i>, <i>31</i>(3), 228–231. <a href="https://doi.org/10.4103/0970-2113.135760">https://doi.org/10.4103/0970-2113.135760</a></div>
  <span class="Z3988" title="url_ver=Z39.88-2004&amp;ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fzotero.org%3A2&amp;rft_id=info%3Adoi%2F10.4103%2F0970-2113.135760&amp;rft_id=info%3Apmid%2F25125808&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Primary%20mediastinal%20large%20B-cell%20lymphoma%3A%20Clinical%20features%2C%20prognostic%20factors%20and%20survival%20with%20RCHOP%20in%20Arab%20patients%20in%20the%20PET%20scan%20era&amp;rft.jtitle=Lung%20India%20%3A%20Official%20Organ%20of%20Indian%20Chest%20Society&amp;rft.stitle=Lung%20India&amp;rft.volume=31&amp;rft.issue=3&amp;rft.aufirst=Salem&amp;rft.aulast=Al%20Shemmari&amp;rft.au=Salem%20Al%20Shemmari&amp;rft.au=Sreedharan%20P.%20Sankaranarayanan&amp;rft.au=Yamini%20Krishnan&amp;rft.date=2014&amp;rft.pages=228-231&amp;rft.spage=228&amp;rft.epage=231&amp;rft.issn=0970-2113"></span>
  <div class="csl-entry">Aoki, T., Izutsu, K., Suzuki, R., Nakaseko, C., Arima, H., Shimada, K., Tomita, A., Sasaki, M., Takizawa, J., Mitani, K., Igarashi, T., Maeda, Y., Fukuhara, N., Ishida, F., Niitsu, N., Ohmachi, K., Takasaki, H., Nakamura, N., Kinoshita, T., … Ogura, M. (2014). Prognostic significance of pleural or pericardial effusion and the implication of optimal treatment in primary mediastinal large B-cell lymphoma: A multicenter retrospective study in Japan. <i>Haematologica</i>, <i>99</i>(12), 1817–1825. <a href="https://doi.org/10.3324/haematol.2014.111203">https://doi.org/10.3324/haematol.2014.111203</a></div>
  <span class="Z3988" title="url_ver=Z39.88-2004&amp;ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fzotero.org%3A2&amp;rft_id=info%3Adoi%2F10.3324%2Fhaematol.2014.111203&amp;rft_id=info%3Apmid%2F25216682&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Prognostic%20significance%20of%20pleural%20or%20pericardial%20effusion%20and%20the%20implication%20of%20optimal%20treatment%20in%20primary%20mediastinal%20large%20B-cell%20lymphoma%3A%20a%20multicenter%20retrospective%20study%20in%20Japan&amp;rft.jtitle=Haematologica&amp;rft.stitle=Haematologica&amp;rft.volume=99&amp;rft.issue=12&amp;rft.aufirst=Tomohiro&amp;rft.aulast=Aoki&amp;rft.au=Tomohiro%20Aoki&amp;rft.au=Koji%20Izutsu&amp;rft.au=Ritsuro%20Suzuki&amp;rft.au=Chiaki%20Nakaseko&amp;rft.au=Hiroshi%20Arima&amp;rft.au=Kazuyuki%20Shimada&amp;rft.au=Akihiro%20Tomita&amp;rft.au=Makoto%20Sasaki&amp;rft.au=Jun%20Takizawa&amp;rft.au=Kinuko%20Mitani&amp;rft.au=Tadahiko%20Igarashi&amp;rft.au=Yoshinobu%20Maeda&amp;rft.au=Noriko%20Fukuhara&amp;rft.au=Fumihiro%20Ishida&amp;rft.au=Nozomi%20Niitsu&amp;rft.au=Ken%20Ohmachi&amp;rft.au=Hirotaka%20Takasaki&amp;rft.au=Naoya%20Nakamura&amp;rft.au=Tomohiro%20Kinoshita&amp;rft.au=Shigeo%20Nakamura&amp;rft.au=Michinori%20Ogura&amp;rft.date=2014-12&amp;rft.pages=1817-1825&amp;rft.spage=1817&amp;rft.epage=1825&amp;rft.issn=1592-8721&amp;rft.language=eng"></span>
  <div class="csl-entry">Bea, S., Zettl, A., Wright, G., Salaverria, I., Jehn, P., Moreno, V., Burek, C., Ott, G., Puig, X., Yang, L., Lopez-Guillermo, A., Chan, W. C., Greiner, T. C., Weisenburger, D. D., Armitage, J. O., Gascoyne, R. D., Connors, J. M., Grogan, T. M., Braziel, R., … Lymphoma/Leukemia Molecular Profiling Project. (2005). Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction. <i>Blood</i>, <i>106</i>(9), 3183–3190. <a href="https://doi.org/10.1182/blood-2005-04-1399">https://doi.org/10.1182/blood-2005-04-1399</a></div>
  <span class="Z3988" title="url_ver=Z39.88-2004&amp;ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fzotero.org%3A2&amp;rft_id=info%3Adoi%2F10.1182%2Fblood-2005-04-1399&amp;rft_id=info%3Apmid%2F16046532&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Diffuse%20large%20B-cell%20lymphoma%20subgroups%20have%20distinct%20genetic%20profiles%20that%20influence%20tumor%20biology%20and%20improve%20gene-expression-based%20survival%20prediction&amp;rft.jtitle=Blood&amp;rft.stitle=Blood&amp;rft.volume=106&amp;rft.issue=9&amp;rft.aufirst=Silvia&amp;rft.aulast=Bea&amp;rft.au=Silvia%20Bea&amp;rft.au=Andreas%20Zettl&amp;rft.au=George%20Wright&amp;rft.au=Itziar%20Salaverria&amp;rft.au=Philipp%20Jehn&amp;rft.au=Victor%20Moreno&amp;rft.au=Christof%20Burek&amp;rft.au=German%20Ott&amp;rft.au=Xavier%20Puig&amp;rft.au=Liming%20Yang&amp;rft.au=Armando%20Lopez-Guillermo&amp;rft.au=Wing%20C.%20Chan&amp;rft.au=Timothy%20C.%20Greiner&amp;rft.au=Dennis%20D.%20Weisenburger&amp;rft.au=James%20O.%20Armitage&amp;rft.au=Randy%20D.%20Gascoyne&amp;rft.au=Joseph%20M.%20Connors&amp;rft.au=Thomas%20M.%20Grogan&amp;rft.au=Rita%20Braziel&amp;rft.au=Richard%20I.%20Fisher&amp;rft.au=Erlend%20B.%20Smeland&amp;rft.au=Stein%20Kvaloy&amp;rft.au=Harald%20Holte&amp;rft.au=Jan%20Delabie&amp;rft.au=Richard%20Simon&amp;rft.au=John%20Powell&amp;rft.au=Wyndham%20H.%20Wilson&amp;rft.au=Elaine%20S.%20Jaffe&amp;rft.au=Emili%20Montserrat&amp;rft.au=Hans-Konrad%20Muller-Hermelink&amp;rft.au=Louis%20M.%20Staudt&amp;rft.au=Elias%20Campo&amp;rft.au=Andreas%20Rosenwald&amp;rft.au=undefined&amp;rft.date=2005-11-01&amp;rft.pages=3183-3190&amp;rft.spage=3183&amp;rft.epage=3190&amp;rft.issn=0006-4971&amp;rft.language=eng"></span>
  <div class="csl-entry">Belay, Y., Yirdaw, K., &amp; Enawgaw, B. (2017). Tumor Lysis Syndrome in Patients with Hematological Malignancies. <i>Journal of Oncology</i>, <i>2017</i>, 9684909. <a href="https://doi.org/10.1155/2017/9684909">https://doi.org/10.1155/2017/9684909</a></div>
  <span class="Z3988" title="url_ver=Z39.88-2004&amp;ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fzotero.org%3A2&amp;rft_id=info%3Adoi%2F10.1155%2F2017%2F9684909&amp;rft_id=info%3Apmid%2F29230244&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Tumor%20Lysis%20Syndrome%20in%20Patients%20with%20Hematological%20Malignancies&amp;rft.jtitle=Journal%20of%20Oncology&amp;rft.stitle=J%20Oncol&amp;rft.volume=2017&amp;rft.aufirst=Yohannes&amp;rft.aulast=Belay&amp;rft.au=Yohannes%20Belay&amp;rft.au=Ketsela%20Yirdaw&amp;rft.au=Bamlaku%20Enawgaw&amp;rft.date=2017&amp;rft.pages=9684909&amp;rft.issn=1687-8450"></span>
  <div class="csl-entry">Bhatt, V. R., Mourya, R., Shrestha, R., &amp; Armitage, J. O. (2015). Primary mediastinal large B-cell lymphoma. <i>Cancer Treatment Reviews</i>, <i>41</i>(6), 476–485. <a href="https://doi.org/10.1016/j.ctrv.2015.04.006">https://doi.org/10.1016/j.ctrv.2015.04.006</a></div>
  <span class="Z3988" title="url_ver=Z39.88-2004&amp;ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fzotero.org%3A2&amp;rft_id=info%3Adoi%2F10.1016%2Fj.ctrv.2015.04.006&amp;rft_id=info%3Apmid%2F25913715&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Primary%20mediastinal%20large%20B-cell%20lymphoma&amp;rft.jtitle=Cancer%20Treatment%20Reviews&amp;rft.stitle=Cancer%20Treat%20Rev&amp;rft.volume=41&amp;rft.issue=6&amp;rft.aufirst=Vijaya%20Raj&amp;rft.aulast=Bhatt&amp;rft.au=Vijaya%20Raj%20Bhatt&amp;rft.au=Rajesh%20Mourya&amp;rft.au=Runa%20Shrestha&amp;rft.au=James%20O.%20Armitage&amp;rft.date=2015-06&amp;rft.pages=476-485&amp;rft.spage=476&amp;rft.epage=485&amp;rft.issn=1532-1967&amp;rft.language=eng"></span>
  <div class="csl-entry">Bishop, P. C., Wilson, W. H., Pearson, D., Janik, J., Jaffe, E. S., &amp; Elwood, P. C. (1999). CNS involvement in primary mediastinal large B-cell lymphoma. <i>Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology</i>, <i>17</i>(8), 2479–2485. <a href="https://doi.org/10.1200/JCO.1999.17.8.2479">https://doi.org/10.1200/JCO.1999.17.8.2479</a></div>
  <span class="Z3988" title="url_ver=Z39.88-2004&amp;ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fzotero.org%3A2&amp;rft_id=info%3Adoi%2F10.1200%2FJCO.1999.17.8.2479&amp;rft_id=info%3Apmid%2F10561312&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=CNS%20involvement%20in%20primary%20mediastinal%20large%20B-cell%20lymphoma&amp;rft.jtitle=Journal%20of%20Clinical%20Oncology%3A%20Official%20Journal%20of%20the%20American%20Society%20of%20Clinical%20Oncology&amp;rft.stitle=J%20Clin%20Oncol&amp;rft.volume=17&amp;rft.issue=8&amp;rft.aufirst=P.%20C.&amp;rft.aulast=Bishop&amp;rft.au=P.%20C.%20Bishop&amp;rft.au=W.%20H.%20Wilson&amp;rft.au=D.%20Pearson&amp;rft.au=J.%20Janik&amp;rft.au=E.%20S.%20Jaffe&amp;rft.au=P.%20C.%20Elwood&amp;rft.date=1999-08&amp;rft.pages=2479-2485&amp;rft.spage=2479&amp;rft.epage=2485&amp;rft.issn=0732-183X&amp;rft.language=eng"></span>

</div>

---

# Bibliography

<div class="csl-bib-body text-sm" style="line-height: 1.35; margin-left: 2em; text-indent:-2em;">
  <div class="csl-entry">Camus, V., Drieux, F., &amp; Jardin, F. (2022). State of the art in the diagnosis, biology and treatment of primary mediastinal B-cell lymphoma: A review. <i>Annals of Lymphoma</i>, <i>6</i>(0), Article 0. <a href="https://doi.org/10.21037/aol-22-13">https://doi.org/10.21037/aol-22-13</a></div>
  <span class="Z3988" title="url_ver=Z39.88-2004&amp;ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fzotero.org%3A2&amp;rft_id=info%3Adoi%2F10.21037%2Faol-22-13&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=State%20of%20the%20art%20in%20the%20diagnosis%2C%20biology%20and%20treatment%20of%20primary%20mediastinal%20B-cell%20lymphoma%3A%20a%20review&amp;rft.jtitle=Annals%20of%20Lymphoma&amp;rft.volume=6&amp;rft.issue=0&amp;rft.aufirst=Vincent&amp;rft.aulast=Camus&amp;rft.au=Vincent%20Camus&amp;rft.au=Fanny%20Drieux&amp;rft.au=Fabrice%20Jardin&amp;rft.date=2022-12-30&amp;rft.issn=2616-2695&amp;rft.language=en"></span>
  <div class="csl-entry">Cazals-Hatem, D., Lepage, E., Brice, P., Ferrant, A., d’Agay, M. F., Baumelou, E., Brière, J., Blanc, M., Gaulard, P., Biron, P., Schlaifer, D., Diebold, J., &amp; Audouin, J. (1996). Primary mediastinal large B-cell lymphoma. A clinicopathologic study of 141 cases compared with 916 nonmediastinal large B-cell lymphomas, a GELA (“Groupe d’Etude des Lymphomes de l’Adulte”) study. <i>The American Journal of Surgical Pathology</i>, <i>20</i>(7), 877–888. <a href="https://doi.org/10.1097/00000478-199607000-00012">https://doi.org/10.1097/00000478-199607000-00012</a></div>
  <span class="Z3988" title="url_ver=Z39.88-2004&amp;ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fzotero.org%3A2&amp;rft_id=info%3Adoi%2F10.1097%2F00000478-199607000-00012&amp;rft_id=info%3Apmid%2F8669537&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Primary%20mediastinal%20large%20B-cell%20lymphoma.%20A%20clinicopathologic%20study%20of%20141%20cases%20compared%20with%20916%20nonmediastinal%20large%20B-cell%20lymphomas%2C%20a%20GELA%20(%22Groupe%20d'Etude%20des%20Lymphomes%20de%20l'Adulte%22)%20study&amp;rft.jtitle=The%20American%20Journal%20of%20Surgical%20Pathology&amp;rft.stitle=Am%20J%20Surg%20Pathol&amp;rft.volume=20&amp;rft.issue=7&amp;rft.aufirst=D.&amp;rft.aulast=Cazals-Hatem&amp;rft.au=D.%20Cazals-Hatem&amp;rft.au=E.%20Lepage&amp;rft.au=P.%20Brice&amp;rft.au=A.%20Ferrant&amp;rft.au=M.%20F.%20d'Agay&amp;rft.au=E.%20Baumelou&amp;rft.au=J.%20Bri%C3%A8re&amp;rft.au=M.%20Blanc&amp;rft.au=P.%20Gaulard&amp;rft.au=P.%20Biron&amp;rft.au=D.%20Schlaifer&amp;rft.au=J.%20Diebold&amp;rft.au=J.%20Audouin&amp;rft.date=1996-07&amp;rft.pages=877-888&amp;rft.spage=877&amp;rft.epage=888&amp;rft.issn=0147-5185&amp;rft.language=eng"></span>
  <div class="csl-entry">Chen, H., Pan, T., He, Y., Zeng, R., Li, Y., Yi, L., Zang, H., Chen, S., Duan, Q., Xiao, L., &amp; Zhou, H. (2021). Primary Mediastinal B-Cell Lymphoma: Novel Precision Therapies and Future Directions. <i>Frontiers in Oncology</i>, <i>11</i>. <a href="https://www.frontiersin.org/articles/10.3389/fonc.2021.654854">https://www.frontiersin.org/articles/10.3389/fonc.2021.654854</a></div>
  <span class="Z3988" title="url_ver=Z39.88-2004&amp;ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fzotero.org%3A2&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Primary%20Mediastinal%20B-Cell%20Lymphoma%3A%20Novel%20Precision%20Therapies%20and%20Future%20Directions&amp;rft.jtitle=Frontiers%20in%20Oncology&amp;rft.volume=11&amp;rft.aufirst=Huan&amp;rft.aulast=Chen&amp;rft.au=Huan%20Chen&amp;rft.au=Tao%20Pan&amp;rft.au=Yizi%20He&amp;rft.au=Ruolan%20Zeng&amp;rft.au=Yajun%20Li&amp;rft.au=Liming%20Yi&amp;rft.au=Hui%20Zang&amp;rft.au=Siwei%20Chen&amp;rft.au=Qintong%20Duan&amp;rft.au=Ling%20Xiao&amp;rft.au=Hui%20Zhou&amp;rft.date=2021&amp;rft.issn=2234-943X"></span>
  <div class="csl-entry">Cwynarski, K., Marzolini, M. A. V., Barrington, S. F., Follows, G., Illidge, T., Stern, S., Davies, A., &amp; Guidelines,  the B. S. for H. (2019). The management of primary mediastinal B-cell lymphoma: A British Society for Haematology Good Practice Paper. <i>British Journal of Haematology</i>, <i>185</i>(3), 402–409. <a href="https://doi.org/10.1111/bjh.15731">https://doi.org/10.1111/bjh.15731</a></div>
  <span class="Z3988" title="url_ver=Z39.88-2004&amp;ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fzotero.org%3A2&amp;rft_id=info%3Adoi%2F10.1111%2Fbjh.15731&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=The%20management%20of%20primary%20mediastinal%20B-cell%20lymphoma%3A%20a%20British%20Society%20for%20Haematology%20Good%20Practice%20Paper&amp;rft.jtitle=British%20Journal%20of%20Haematology&amp;rft.volume=185&amp;rft.issue=3&amp;rft.aufirst=Kate&amp;rft.aulast=Cwynarski&amp;rft.au=Kate%20Cwynarski&amp;rft.au=Maria%20A.%20V.%20Marzolini&amp;rft.au=Sally%20F.%20Barrington&amp;rft.au=George%20Follows&amp;rft.au=Timothy%20Illidge&amp;rft.au=Simon%20Stern&amp;rft.au=Andrew%20Davies&amp;rft.au=the%20British%20Society%20for%20Haematology%20Guidelines&amp;rft.date=2019&amp;rft.pages=402-409&amp;rft.spage=402&amp;rft.epage=409&amp;rft.issn=1365-2141&amp;rft.language=en"></span>
  <div class="csl-entry">Dunleavy, K., Pittaluga, S., Maeda, L. S., Advani, R., Chen, C. C., Hessler, J., Steinberg, S. M., Grant, C., Wright, G., Varma, G., Staudt, L. M., Jaffe, E. S., &amp; Wilson, W. H. (2013). Dose-Adjusted EPOCH-Rituximab Therapy in Primary Mediastinal B-Cell Lymphoma. <i>New England Journal of Medicine</i>, <i>368</i>(15), 1408–1416. <a href="https://doi.org/10.1056/NEJMoa1214561">https://doi.org/10.1056/NEJMoa1214561</a></div>
  <span class="Z3988" title="url_ver=Z39.88-2004&amp;ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fzotero.org%3A2&amp;rft_id=info%3Adoi%2F10.1056%2FNEJMoa1214561&amp;rft_id=info%3Apmid%2F23574119&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Dose-Adjusted%20EPOCH-Rituximab%20Therapy%20in%20Primary%20Mediastinal%20B-Cell%20Lymphoma&amp;rft.jtitle=New%20England%20Journal%20of%20Medicine&amp;rft.volume=368&amp;rft.issue=15&amp;rft.aufirst=Kieron&amp;rft.aulast=Dunleavy&amp;rft.au=Kieron%20Dunleavy&amp;rft.au=Stefania%20Pittaluga&amp;rft.au=Lauren%20S.%20Maeda&amp;rft.au=Ranjana%20Advani&amp;rft.au=Clara%20C.%20Chen&amp;rft.au=Julie%20Hessler&amp;rft.au=Seth%20M.%20Steinberg&amp;rft.au=Cliona%20Grant&amp;rft.au=George%20Wright&amp;rft.au=Gaurav%20Varma&amp;rft.au=Louis%20M.%20Staudt&amp;rft.au=Elaine%20S.%20Jaffe&amp;rft.au=Wyndham%20H.%20Wilson&amp;rft.date=2013-04-11&amp;rft.pages=1408-1416&amp;rft.spage=1408&amp;rft.epage=1416&amp;rft.issn=0028-4793"></span>
  <div class="csl-entry">Hayden, A. R., Tonseth, P., Lee, D. G., Villa, D., Gerrie, A. S., Scott, D. W., Freeman, C. L., Slack, G. W., Farinha, P., Skinnider, B., Yenson, P. R., Benard, F., Lo, A., Pickles, T., Wilson, D., Connors, J. M., Sehn, L. H., &amp; Savage, K. J. (2020). Outcome of primary mediastinal large B-cell lymphoma using R-CHOP: Impact of a PET-adapted approach. <i>Blood</i>, <i>136</i>(24), 2803–2811. <a href="https://doi.org/10.1182/blood.2019004296">https://doi.org/10.1182/blood.2019004296</a></div>
  <span class="Z3988" title="url_ver=Z39.88-2004&amp;ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fzotero.org%3A2&amp;rft_id=info%3Adoi%2F10.1182%2Fblood.2019004296&amp;rft_id=info%3Apmid%2F32603413&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Outcome%20of%20primary%20mediastinal%20large%20B-cell%20lymphoma%20using%20R-CHOP%3A%20impact%20of%20a%20PET-adapted%20approach&amp;rft.jtitle=Blood&amp;rft.stitle=Blood&amp;rft.volume=136&amp;rft.issue=24&amp;rft.aufirst=Anna%20R.&amp;rft.aulast=Hayden&amp;rft.au=Anna%20R.%20Hayden&amp;rft.au=Petter%20Tonseth&amp;rft.au=Derrick%20G.%20Lee&amp;rft.au=Diego%20Villa&amp;rft.au=Alina%20S.%20Gerrie&amp;rft.au=David%20W.%20Scott&amp;rft.au=Ciara%20L.%20Freeman&amp;rft.au=Graham%20W.%20Slack&amp;rft.au=Pedro%20Farinha&amp;rft.au=Brian%20Skinnider&amp;rft.au=Paul%20R.%20Yenson&amp;rft.au=Francois%20Benard&amp;rft.au=Andrea%20Lo&amp;rft.au=Tom%20Pickles&amp;rft.au=Donald%20Wilson&amp;rft.au=Joseph%20M.%20Connors&amp;rft.au=Laurie%20H.%20Sehn&amp;rft.au=Kerry%20J.%20Savage&amp;rft.date=2020-12-10&amp;rft.pages=2803-2811&amp;rft.spage=2803&amp;rft.epage=2811&amp;rft.issn=1528-0020&amp;rft.language=eng"></span>
  <div class="csl-entry">Jacobson, J. O., Aisenberg, A. C., Lamarre, L., Willett, C. G., Linggood, R. M., Miketic, L. M., &amp; Harris, N. L. (1988). Mediastinal large cell lymphoma. An uncommon subset of adult lymphoma curable with combined modality therapy. <i>Cancer</i>, <i>62</i>(9), 1893–1898. <a href="https://doi.org/10.1002/1097-0142(19881101)62:9<1893::aid-cncr2820620904>3.0.co;2-x">https://doi.org/10.1002/1097-0142(19881101)62:9&lt;1893::aid-cncr2820620904&gt;3.0.co;2-x</a></div>
  <span class="Z3988" title="url_ver=Z39.88-2004&amp;ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fzotero.org%3A2&amp;rft_id=info%3Adoi%2F10.1002%2F1097-0142(19881101)62%3A9%3C1893%3A%3Aaid-cncr2820620904%3E3.0.co%3B2-x&amp;rft_id=info%3Apmid%2F3167803&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Mediastinal%20large%20cell%20lymphoma.%20An%20uncommon%20subset%20of%20adult%20lymphoma%20curable%20with%20combined%20modality%20therapy&amp;rft.jtitle=Cancer&amp;rft.stitle=Cancer&amp;rft.volume=62&amp;rft.issue=9&amp;rft.aufirst=J.%20O.&amp;rft.aulast=Jacobson&amp;rft.au=J.%20O.%20Jacobson&amp;rft.au=A.%20C.%20Aisenberg&amp;rft.au=L.%20Lamarre&amp;rft.au=C.%20G.%20Willett&amp;rft.au=R.%20M.%20Linggood&amp;rft.au=L.%20M.%20Miketic&amp;rft.au=N.%20L.%20Harris&amp;rft.date=1988-11-01&amp;rft.pages=1893-1898&amp;rft.spage=1893&amp;rft.epage=1898&amp;rft.issn=0008-543X&amp;rft.language=eng"></span>

</div>

---

# Bibliography

<div class="csl-bib-body text-sm" style="line-height: 1.35; margin-left: 2em; text-indent:-2em;">
  <div class="csl-entry">Lees, C., Keane, C., Gandhi, M. K., &amp; Gunawardana, J. (2019). Biology and therapy of primary mediastinal B-cell lymphoma: Current status and future directions. <i>British Journal of Haematology</i>, <i>185</i>(1), 25–41. <a href="https://doi.org/10.1111/bjh.15778">https://doi.org/10.1111/bjh.15778</a></div>
  <span class="Z3988" title="url_ver=Z39.88-2004&amp;ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fzotero.org%3A2&amp;rft_id=info%3Adoi%2F10.1111%2Fbjh.15778&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Biology%20and%20therapy%20of%20primary%20mediastinal%20B-cell%20lymphoma%3A%20current%20status%20and%20future%20directions&amp;rft.jtitle=British%20Journal%20of%20Haematology&amp;rft.volume=185&amp;rft.issue=1&amp;rft.aufirst=Charlotte&amp;rft.aulast=Lees&amp;rft.au=Charlotte%20Lees&amp;rft.au=Colm%20Keane&amp;rft.au=Maher%20K.%20Gandhi&amp;rft.au=Jay%20Gunawardana&amp;rft.date=2019&amp;rft.pages=25-41&amp;rft.spage=25&amp;rft.epage=41&amp;rft.issn=1365-2141&amp;rft.language=en"></span>
  <div class="csl-entry">Lekovic, D., Miljic, P., &amp; Mihaljevic, B. (2010). Increased risk of venous thromboembolism in patients with primary mediastinal large B-cell lymphoma. <i>Thrombosis Research</i>, <i>126</i>(6), 477–480. <a href="https://doi.org/10.1016/j.thromres.2010.08.017">https://doi.org/10.1016/j.thromres.2010.08.017</a></div>
  <span class="Z3988" title="url_ver=Z39.88-2004&amp;ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fzotero.org%3A2&amp;rft_id=info%3Adoi%2F10.1016%2Fj.thromres.2010.08.017&amp;rft_id=info%3Apmid%2F21126629&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Increased%20risk%20of%20venous%20thromboembolism%20in%20patients%20with%20primary%20mediastinal%20large%20B-cell%20lymphoma&amp;rft.jtitle=Thrombosis%20Research&amp;rft.stitle=Thromb%20Res&amp;rft.volume=126&amp;rft.issue=6&amp;rft.aufirst=Danijela&amp;rft.aulast=Lekovic&amp;rft.au=Danijela%20Lekovic&amp;rft.au=Predrag%20Miljic&amp;rft.au=Biljana%20Mihaljevic&amp;rft.date=2010-12&amp;rft.pages=477-480&amp;rft.spage=477&amp;rft.epage=480&amp;rft.issn=1879-2472&amp;rft.language=eng"></span>
  <div class="csl-entry">Martelli, M., Ferreri, A., Di Rocco, A., Ansuinelli, M., &amp; Johnson, P. W. M. (2017). Primary mediastinal large B-cell lymphoma. <i>Critical Reviews in Oncology/Hematology</i>, <i>113</i>, 318–327. <a href="https://doi.org/10.1016/j.critrevonc.2017.01.009">https://doi.org/10.1016/j.critrevonc.2017.01.009</a></div>
  <span class="Z3988" title="url_ver=Z39.88-2004&amp;ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fzotero.org%3A2&amp;rft_id=info%3Adoi%2F10.1016%2Fj.critrevonc.2017.01.009&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Primary%20mediastinal%20large%20B-cell%20lymphoma&amp;rft.jtitle=Critical%20Reviews%20in%20Oncology%2FHematology&amp;rft.stitle=Critical%20Reviews%20in%20Oncology%2FHematology&amp;rft.volume=113&amp;rft.aufirst=Maurizio&amp;rft.aulast=Martelli&amp;rft.au=Maurizio%20Martelli&amp;rft.au=Andr%C3%A9s%20Ferreri&amp;rft.au=Alice%20Di%20Rocco&amp;rft.au=Michela%20Ansuinelli&amp;rft.au=Peter%20W.%20M.%20Johnson&amp;rft.date=2017-05-01&amp;rft.pages=318-327&amp;rft.spage=318&amp;rft.epage=327&amp;rft.issn=1040-8428"></span>
  <div class="csl-entry">National Cancer Institute (NCI). (2023). <i>A Randomized Phase 3 Trial of Nivolumab (NSC# 748726) in Combination With Chemo-Immunotherapy for the Treatment of Newly Diagnosed Primary Mediastinal B-Cell Lymphoma</i> (Clinical Trial Registration NCT04759586). clinicaltrials.gov. <a href="https://clinicaltrials.gov/study/NCT04759586">https://clinicaltrials.gov/study/NCT04759586</a></div>
  <span class="Z3988" title="url_ver=Z39.88-2004&amp;ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fzotero.org%3A2&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=report&amp;rft.btitle=A%20Randomized%20Phase%203%20Trial%20of%20Nivolumab%20(NSC%23%20748726)%20in%20Combination%20With%20Chemo-Immunotherapy%20for%20the%20Treatment%20of%20Newly%20Diagnosed%20Primary%20Mediastinal%20B-Cell%20Lymphoma&amp;rft.au=undefined&amp;rft.date=2023-12-12"></span>
  <div class="csl-entry">Neelapu, S. S., Jacobson, C. A., Ghobadi, A., Miklos, D. B., Lekakis, L. J., Oluwole, O. O., Lin, Y., Braunschweig, I., Hill, B. T., Timmerman, J. M., Deol, A., Reagan, P. M., Stiff, P., Flinn, I. W., Farooq, U., Goy, A. H., McSweeney, P. A., Munoz, J., Siddiqi, T., … Locke, F. L. (2023). Five-year follow-up of ZUMA-1 supports the curative potential of axicabtagene ciloleucel in refractory large&nbsp;B-cell lymphoma. <i>Blood</i>, <i>141</i>(19), 2307–2315. <a href="https://doi.org/10.1182/blood.2022018893">https://doi.org/10.1182/blood.2022018893</a></div>
  <span class="Z3988" title="url_ver=Z39.88-2004&amp;ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fzotero.org%3A2&amp;rft_id=info%3Adoi%2F10.1182%2Fblood.2022018893&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Five-year%20follow-up%20of%20ZUMA-1%20supports%20the%20curative%20potential%20of%20axicabtagene%20ciloleucel%20in%20refractory%20large%C2%A0B-cell%20lymphoma&amp;rft.jtitle=Blood&amp;rft.stitle=Blood&amp;rft.volume=141&amp;rft.issue=19&amp;rft.aufirst=Sattva%20S.&amp;rft.aulast=Neelapu&amp;rft.au=Sattva%20S.%20Neelapu&amp;rft.au=Caron%20A.%20Jacobson&amp;rft.au=Armin%20Ghobadi&amp;rft.au=David%20B.%20Miklos&amp;rft.au=Lazaros%20J.%20Lekakis&amp;rft.au=Olalekan%20O.%20Oluwole&amp;rft.au=Yi%20Lin&amp;rft.au=Ira%20Braunschweig&amp;rft.au=Brian%20T.%20Hill&amp;rft.au=John%20M.%20Timmerman&amp;rft.au=Abhinav%20Deol&amp;rft.au=Patrick%20M.%20Reagan&amp;rft.au=Patrick%20Stiff&amp;rft.au=Ian%20W.%20Flinn&amp;rft.au=Umar%20Farooq&amp;rft.au=Andre%20H.%20Goy&amp;rft.au=Peter%20A.%20McSweeney&amp;rft.au=Javier%20Munoz&amp;rft.au=Tanya%20Siddiqi&amp;rft.au=Julio%20C.%20Chavez&amp;rft.au=Alex%20F.%20Herrera&amp;rft.au=Nancy%20L.%20Bartlett&amp;rft.au=Adrian%20A.%20Bot&amp;rft.au=Rhine%20R.%20Shen&amp;rft.au=Jinghui%20Dong&amp;rft.au=Kanwarjit%20Singh&amp;rft.au=Harry%20Miao&amp;rft.au=Jenny%20J.%20Kim&amp;rft.au=Yan%20Zheng&amp;rft.au=Frederick%20L.%20Locke&amp;rft.date=2023-05-11&amp;rft.pages=2307-2315&amp;rft.spage=2307&amp;rft.epage=2315&amp;rft.issn=0006-4971"></span>
  <div class="csl-entry">Papageorgiou, S. G., Diamantopoulos, P., Levidou, G., Angelopoulou, M. K., Economopoulou, P., Efthimiou, A., Constantinou, N., Katsigiannis, A., Korkolopoulou, P., Pappa, V., Economopoulou, C., Georgiou, G., Dimou, M., Tsirigotis, P., Kyrtsonis, M.-C., Kotsianidis, I., Kalpadakis, C., Dimopoulos, M.-A., Beris, P., … Vassilakopoulos, T. P. (2013). Isolated central nervous system relapses in primary mediastinal large B-cell lymphoma after CHOP-like chemotherapy with or without Rituximab. <i>Hematological Oncology</i>, <i>31</i>(1), 10–17. <a href="https://doi.org/10.1002/hon.2012">https://doi.org/10.1002/hon.2012</a></div>
  <span class="Z3988" title="url_ver=Z39.88-2004&amp;ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fzotero.org%3A2&amp;rft_id=info%3Adoi%2F10.1002%2Fhon.2012&amp;rft_id=info%3Apmid%2F22610484&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Isolated%20central%20nervous%20system%20relapses%20in%20primary%20mediastinal%20large%20B-cell%20lymphoma%20after%20CHOP-like%20chemotherapy%20with%20or%20without%20Rituximab&amp;rft.jtitle=Hematological%20Oncology&amp;rft.stitle=Hematol%20Oncol&amp;rft.volume=31&amp;rft.issue=1&amp;rft.aufirst=Sotirios%20G.&amp;rft.aulast=Papageorgiou&amp;rft.au=Sotirios%20G.%20Papageorgiou&amp;rft.au=Panayiotis%20Diamantopoulos&amp;rft.au=Georgia%20Levidou&amp;rft.au=Maria%20K.%20Angelopoulou&amp;rft.au=Panagiota%20Economopoulou&amp;rft.au=Anna%20Efthimiou&amp;rft.au=Nikos%20Constantinou&amp;rft.au=Andreas%20Katsigiannis&amp;rft.au=Penelope%20Korkolopoulou&amp;rft.au=Vassiliki%20Pappa&amp;rft.au=Christina%20Economopoulou&amp;rft.au=George%20Georgiou&amp;rft.au=Maria%20Dimou&amp;rft.au=Panagiotis%20Tsirigotis&amp;rft.au=Marie-Christine%20Kyrtsonis&amp;rft.au=Ioannis%20Kotsianidis&amp;rft.au=Christina%20Kalpadakis&amp;rft.au=Meletios-Athanassios%20Dimopoulos&amp;rft.au=Photis%20Beris&amp;rft.au=John%20Meletis&amp;rft.au=Gerassimos%20A.%20Pangalis&amp;rft.au=John%20Dervenoulas&amp;rft.au=Panayiotis%20Panayiotidis&amp;rft.au=Theodoros%20P.%20Vassilakopoulos&amp;rft.date=2013-03&amp;rft.pages=10-17&amp;rft.spage=10&amp;rft.epage=17&amp;rft.issn=1099-1069&amp;rft.language=eng"></span>
  <div class="csl-entry">Purroy, N., Bergua, J., Gallur, L., Prieto, J., Lopez, L. A., Sancho, J. M., García-Marco, J. A., Castellví, J., Montes-Moreno, S., Batlle, A., de Villambrosia, S. G., Carnicero, F., Ferrando-Lamana, L., Piris, M. A., &amp; Lopez, A. (2015). Long-term follow-up of dose-adjusted EPOCH plus rituximab (DA-EPOCH-R) in untreated patients with poor prognosis large B-cell lymphoma. A phase II study conducted by the Spanish PETHEMA Group. <i>British Journal of Haematology</i>, <i>169</i>(2), 188–198. <a href="https://doi.org/10.1111/bjh.13273">https://doi.org/10.1111/bjh.13273</a></div>
  <span class="Z3988" title="url_ver=Z39.88-2004&amp;ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fzotero.org%3A2&amp;rft_id=info%3Adoi%2F10.1111%2Fbjh.13273&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Long-term%20follow-up%20of%20dose-adjusted%20EPOCH%20plus%20rituximab%20(DA-EPOCH-R)%20in%20untreated%20patients%20with%20poor%20prognosis%20large%20B-cell%20lymphoma.%20A%20phase%20II%20study%20conducted%20by%20the%20Spanish%20PETHEMA%20Group&amp;rft.jtitle=British%20Journal%20of%20Haematology&amp;rft.volume=169&amp;rft.issue=2&amp;rft.aufirst=Noelia&amp;rft.aulast=Purroy&amp;rft.au=Noelia%20Purroy&amp;rft.au=Juan%20Bergua&amp;rft.au=Laura%20Gallur&amp;rft.au=Julio%20Prieto&amp;rft.au=Luis%20A.%20Lopez&amp;rft.au=Juan%20M.%20Sancho&amp;rft.au=Jose%20A.%20Garc%C3%ADa-Marco&amp;rft.au=Josep%20Castellv%C3%AD&amp;rft.au=Santiago%20Montes-Moreno&amp;rft.au=Ana%20Batlle&amp;rft.au=Sonia%20Gonzalez%20de%20Villambrosia&amp;rft.au=Fernando%20Carnicero&amp;rft.au=Luc%C3%ADa%20Ferrando-Lamana&amp;rft.au=Miguel%20A%20Piris&amp;rft.au=Andr%C3%A9s%20Lopez&amp;rft.date=2015&amp;rft.pages=188-198&amp;rft.spage=188&amp;rft.epage=198&amp;rft.issn=1365-2141&amp;rft.language=en"></span>
</div>

---

# Bibliography

<div class="csl-bib-body text-sm" style="line-height: 1.35; margin-left: 2em; text-indent:-2em;">
  <div class="csl-entry">Savage, K. J., Al-Rajhi, N., Voss, N., Paltiel, C., Klasa, R., Gascoyne, R. D., &amp; Connors, J. M. (2006). Favorable outcome of primary mediastinal large B-cell lymphoma in a single institution: The British Columbia experience. <i>Annals of Oncology: Official Journal of the European Society for Medical Oncology</i>, <i>17</i>(1), 123–130. <a href="https://doi.org/10.1093/annonc/mdj030">https://doi.org/10.1093/annonc/mdj030</a></div>
  <span class="Z3988" title="url_ver=Z39.88-2004&amp;ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fzotero.org%3A2&amp;rft_id=info%3Adoi%2F10.1093%2Fannonc%2Fmdj030&amp;rft_id=info%3Apmid%2F16236753&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Favorable%20outcome%20of%20primary%20mediastinal%20large%20B-cell%20lymphoma%20in%20a%20single%20institution%3A%20the%20British%20Columbia%20experience&amp;rft.jtitle=Annals%20of%20Oncology%3A%20Official%20Journal%20of%20the%20European%20Society%20for%20Medical%20Oncology&amp;rft.stitle=Ann%20Oncol&amp;rft.volume=17&amp;rft.issue=1&amp;rft.aufirst=K.%20J.&amp;rft.aulast=Savage&amp;rft.au=K.%20J.%20Savage&amp;rft.au=N.%20Al-Rajhi&amp;rft.au=N.%20Voss&amp;rft.au=C.%20Paltiel&amp;rft.au=R.%20Klasa&amp;rft.au=R.%20D.%20Gascoyne&amp;rft.au=J.%20M.%20Connors&amp;rft.date=2006-01&amp;rft.pages=123-130&amp;rft.spage=123&amp;rft.epage=130&amp;rft.issn=0923-7534&amp;rft.language=eng"></span>
  <div class="csl-entry">Shah, N. N., Szabo, A., Huntington, S. F., Epperla, N., Reddy, N., Ganguly, S., Vose, J., Obiozor, C., Faruqi, F., Kovach, A. E., Costa, L. J., Xavier, A. C., Okal, R., Kanate, A. S., Ghosh, N., Kharfan-Dabaja, M. A., Strelec, L., Hamadani, M., Fenske, T. S., … Svoboda, J. (2018). R-CHOP versus dose-adjusted R-EPOCH in frontline management of primary mediastinal B-cell lymphoma: A multi-centre analysis. <i>British Journal of Haematology</i>, <i>180</i>(4), 534–544. <a href="https://doi.org/10.1111/bjh.15051">https://doi.org/10.1111/bjh.15051</a></div>
  <span class="Z3988" title="url_ver=Z39.88-2004&amp;ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fzotero.org%3A2&amp;rft_id=info%3Adoi%2F10.1111%2Fbjh.15051&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=R-CHOP%20versus%20dose-adjusted%20R-EPOCH%20in%20frontline%20management%20of%20primary%20mediastinal%20B-cell%20lymphoma%3A%20a%20multi-centre%20analysis&amp;rft.jtitle=British%20Journal%20of%20Haematology&amp;rft.volume=180&amp;rft.issue=4&amp;rft.aufirst=Nirav%20N.&amp;rft.aulast=Shah&amp;rft.au=Nirav%20N.%20Shah&amp;rft.au=Aniko%20Szabo&amp;rft.au=Scott%20F.%20Huntington&amp;rft.au=Narendranath%20Epperla&amp;rft.au=Nishitha%20Reddy&amp;rft.au=Siddhartha%20Ganguly&amp;rft.au=Julie%20Vose&amp;rft.au=Cynthia%20Obiozor&amp;rft.au=Fahad%20Faruqi&amp;rft.au=Alexandra%20E.%20Kovach&amp;rft.au=Luciano%20J.%20Costa&amp;rft.au=Ana%20C.%20Xavier&amp;rft.au=Ryan%20Okal&amp;rft.au=Abraham%20S.%20Kanate&amp;rft.au=Nilanjan%20Ghosh&amp;rft.au=Mohamed%20A.%20Kharfan-Dabaja&amp;rft.au=Lauren%20Strelec&amp;rft.au=Mehdi%20Hamadani&amp;rft.au=Timothy%20S.%20Fenske&amp;rft.au=Oscar%20Calzada&amp;rft.au=Jonathon%20B.%20Cohen&amp;rft.au=Julio%20Chavez&amp;rft.au=Jakub%20Svoboda&amp;rft.date=2018&amp;rft.pages=534-544&amp;rft.spage=534&amp;rft.epage=544&amp;rft.issn=1365-2141&amp;rft.language=en"></span>
  <div class="csl-entry">Sheikh, Y., &amp; Gaillard, F. (2010). Mediastinal lymphoma—Large B-cell. In <i>Radiopaedia.org</i>. Radiopaedia.org. <a href="https://doi.org/10.53347/rID-8655">https://doi.org/10.53347/rID-8655</a></div>
  <span class="Z3988" title="url_ver=Z39.88-2004&amp;ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fzotero.org%3A2&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.atitle=Mediastinal%20lymphoma%20-%20large%20B-cell&amp;rft.publisher=Radiopaedia.org&amp;rft.aufirst=Yusra&amp;rft.aulast=Sheikh&amp;rft.au=Yusra%20Sheikh&amp;rft.au=Frank%20Gaillard&amp;rft.date=2010-02-21&amp;rft.language=en"></span>
  <div class="csl-entry">Velasques, R. D., da Silva, W. F., Bellesso, M., Rocha, V., &amp; Pereira, J. (2022). Less Intensive Regimens May Still Be Suitable for the Initial Treatment of Primary Mediastinal B-Cell Lymphoma in Resource-Limited Settings. <i>Journal of Oncology</i>, <i>2022</i>, 2099456. <a href="https://doi.org/10.1155/2022/2099456">https://doi.org/10.1155/2022/2099456</a></div>
  <span class="Z3988" title="url_ver=Z39.88-2004&amp;ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fzotero.org%3A2&amp;rft_id=info%3Adoi%2F10.1155%2F2022%2F2099456&amp;rft_id=info%3Apmid%2F35706929&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Less%20Intensive%20Regimens%20May%20Still%20Be%20Suitable%20for%20the%20Initial%20Treatment%20of%20Primary%20Mediastinal%20B-Cell%20Lymphoma%20in%20Resource-Limited%20Settings&amp;rft.jtitle=Journal%20of%20Oncology&amp;rft.stitle=J%20Oncol&amp;rft.volume=2022&amp;rft.aufirst=Rodrigo%20Dolphini&amp;rft.aulast=Velasques&amp;rft.au=Rodrigo%20Dolphini%20Velasques&amp;rft.au=Wellington%20F.%20da%20Silva&amp;rft.au=Marcelo%20Bellesso&amp;rft.au=Vanderson%20Rocha&amp;rft.au=Juliana%20Pereira&amp;rft.date=2022&amp;rft.pages=2099456&amp;rft.issn=1687-8450&amp;rft.language=eng"></span>
  <div class="csl-entry">Yu, Y., Dong, X., Tu, M., &amp; Wang, H. (2021). Primary mediastinal large B cell lymphoma. <i>Thoracic Cancer</i>, <i>12</i>(21), 2831–2837. <a href="https://doi.org/10.1111/1759-7714.14155">https://doi.org/10.1111/1759-7714.14155</a></div>
  <span class="Z3988" title="url_ver=Z39.88-2004&amp;ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fzotero.org%3A2&amp;rft_id=info%3Adoi%2F10.1111%2F1759-7714.14155&amp;rft_id=info%3Apmid%2F34590432&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Primary%20mediastinal%20large%20B%20cell%20lymphoma&amp;rft.jtitle=Thoracic%20Cancer&amp;rft.stitle=Thorac%20Cancer&amp;rft.volume=12&amp;rft.issue=21&amp;rft.aufirst=Yating&amp;rft.aulast=Yu&amp;rft.au=Yating%20Yu&amp;rft.au=Xifeng%20Dong&amp;rft.au=Meifeng%20Tu&amp;rft.au=Huaquan%20Wang&amp;rft.date=2021-11&amp;rft.pages=2831-2837&amp;rft.spage=2831&amp;rft.epage=2837&amp;rft.issn=1759-7706"></span>
  <div class="csl-entry">Yuan, J., Wright, G., Rosenwald, A., Steidl, C., Gascoyne, R. D., Connors, J. M., Mottok, A., Weisenburger, D. D., Greiner, T. C., Fu, K., Smith, L., Rimsza, L. M., Jaffe, E. S., Campo, E., Martinez, A., Delabie, J., Braziel, R. M., Cook, J. R., Ott, G., … Project (LLMPP), F. the L. L. M. P. (2015). Identification of Primary Mediastinal Large B-cell Lymphoma at Nonmediastinal Sites by Gene Expression Profiling. <i>The American Journal of Surgical Pathology</i>, <i>39</i>(10), 1322. <a href="https://doi.org/10.1097/PAS.0000000000000473">https://doi.org/10.1097/PAS.0000000000000473</a></div>
  <span class="Z3988" title="url_ver=Z39.88-2004&amp;ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fzotero.org%3A2&amp;rft_id=info%3Adoi%2F10.1097%2FPAS.0000000000000473&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Identification%20of%20Primary%20Mediastinal%20Large%20B-cell%20Lymphoma%20at%20Nonmediastinal%20Sites%20by%20Gene%20Expression%20Profiling&amp;rft.jtitle=The%20American%20Journal%20of%20Surgical%20Pathology&amp;rft.volume=39&amp;rft.issue=10&amp;rft.aufirst=Ji&amp;rft.aulast=Yuan&amp;rft.au=Ji%20Yuan&amp;rft.au=George%20Wright&amp;rft.au=Andreas%20Rosenwald&amp;rft.au=Christian%20Steidl&amp;rft.au=Randy%20D.%20Gascoyne&amp;rft.au=Joseph%20M.%20Connors&amp;rft.au=Anja%20Mottok&amp;rft.au=Dennis%20D.%20Weisenburger&amp;rft.au=Timothy%20C.%20Greiner&amp;rft.au=Kai%20Fu&amp;rft.au=Lynette%20Smith&amp;rft.au=Lisa%20M.%20Rimsza&amp;rft.au=Elaine%20S.%20Jaffe&amp;rft.au=Elias%20Campo&amp;rft.au=Antonio%20Martinez&amp;rft.au=Jan%20Delabie&amp;rft.au=Rita%20M.%20Braziel&amp;rft.au=James%20R.%20Cook&amp;rft.au=German%20Ott&amp;rft.au=Julie%20M.%20Vose&amp;rft.au=Louis%20M.%20Staudt&amp;rft.au=Wing%20C.%20Chan&amp;rft.au=For%20the%20Lymphoma%20Leukemia%20Molecular%20Profiling%20Project%20(LLMPP)&amp;rft.date=2015-10&amp;rft.pages=1322&amp;rft.issn=0147-5185&amp;rft.language=en-US"></span>
</div>

---

# Bibliography

<div class="csl-bib-body text-sm" style="line-height: 1.35; margin-left: 2em; text-indent:-2em;">
  <div class="csl-entry">Zinzani, P. L., Thieblemont, C., Melnichenko, V., Bouabdallah, K., Walewski, J., Majlis, A., Fogliatto, L., Garcia-Sancho, A. M., Christian, B., Gulbas, Z., Özcan, M., Perini, G. F., Ghesquieres, H., Shipp, M. A., Thompson, S., Chakraborty, S., Marinello, P., &amp; Armand, P. (2023). Pembrolizumab in relapsed or refractory primary mediastinal large B-cell lymphoma: Final analysis of KEYNOTE-170. <i>Blood</i>, <i>142</i>(2), 141–145. <a href="https://doi.org/10.1182/blood.2022019340">https://doi.org/10.1182/blood.2022019340</a></div>
  <span class="Z3988" title="url_ver=Z39.88-2004&amp;ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fzotero.org%3A2&amp;rft_id=info%3Adoi%2F10.1182%2Fblood.2022019340&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Pembrolizumab%20in%20relapsed%20or%20refractory%20primary%20mediastinal%20large%20B-cell%20lymphoma%3A%20final%20analysis%20of%20KEYNOTE-170&amp;rft.jtitle=Blood&amp;rft.stitle=Blood&amp;rft.volume=142&amp;rft.issue=2&amp;rft.aufirst=Pier%20Luigi&amp;rft.aulast=Zinzani&amp;rft.au=Pier%20Luigi%20Zinzani&amp;rft.au=Catherine%20Thieblemont&amp;rft.au=Vladimir%20Melnichenko&amp;rft.au=Krimo%20Bouabdallah&amp;rft.au=Jan%20Walewski&amp;rft.au=Alejandro%20Majlis&amp;rft.au=Laura%20Fogliatto&amp;rft.au=A.%20Martin%20Garcia-Sancho&amp;rft.au=Beth%20Christian&amp;rft.au=Zafer%20Gulbas&amp;rft.au=Muhit%20%C3%96zcan&amp;rft.au=Guilherme%20Fleury%20Perini&amp;rft.au=Herve%20Ghesquieres&amp;rft.au=Margaret%20A.%20Shipp&amp;rft.au=Seth%20Thompson&amp;rft.au=Samhita%20Chakraborty&amp;rft.au=Patricia%20Marinello&amp;rft.au=Philippe%20Armand&amp;rft.date=2023-07-13&amp;rft.pages=141-145&amp;rft.spage=141&amp;rft.epage=145&amp;rft.issn=0006-4971"></span>
  <div class="csl-entry">Zucca, E., Davies, A., Kryachok, I., Ciccone, G., Ceriani, L., Botto, B., Mikhaeel, N. G., Dabrowska-Iwanicka, A., Zhao, W., Inescu, C., Janikova, A., Fossa, A., Hodgson, D., Jerkeman, M., Balzarotti, M., Tucci, A., Ricardi, U., Barrington, S., Johnson, P. W. M., &amp; Martelli, M. (2023). Observation vs. radiotherapy in primary mediastinal B-cell lymphoma patients with complete response to standard immunochemotherapy: The IELSG37 randomized trial. <i>Journal of Clinical Oncology</i>, <i>41</i>(17_suppl), LBA7505–LBA7505. <a href="https://doi.org/10.1200/JCO.2023.41.17_suppl.LBA7505">https://doi.org/10.1200/JCO.2023.41.17_suppl.LBA7505</a></div>
  <span class="Z3988" title="url_ver=Z39.88-2004&amp;ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fzotero.org%3A2&amp;rft_id=info%3Adoi%2F10.1200%2FJCO.2023.41.17_suppl.LBA7505&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Observation%20vs.%20radiotherapy%20in%20primary%20mediastinal%20B-cell%20lymphoma%20patients%20with%20complete%20response%20to%20standard%20immunochemotherapy%3A%20The%20IELSG37%20randomized%20trial.&amp;rft.jtitle=Journal%20of%20Clinical%20Oncology&amp;rft.stitle=JCO&amp;rft.volume=41&amp;rft.issue=17_suppl&amp;rft.aufirst=Emanuele&amp;rft.aulast=Zucca&amp;rft.au=Emanuele%20Zucca&amp;rft.au=Andrew%20Davies&amp;rft.au=Irina%20Kryachok&amp;rft.au=Giovannino%20Ciccone&amp;rft.au=Luca%20Ceriani&amp;rft.au=Barbara%20Botto&amp;rft.au=N.%20George%20Mikhaeel&amp;rft.au=Anna%20Dabrowska-Iwanicka&amp;rft.au=Weili%20Zhao&amp;rft.au=Codruta%20Inescu&amp;rft.au=Andrea%20Janikova&amp;rft.au=Alexander%20Fossa&amp;rft.au=David%20Hodgson&amp;rft.au=Mats%20Jerkeman&amp;rft.au=Monica%20Balzarotti&amp;rft.au=Alessandra%20Tucci&amp;rft.au=Umberto%20Ricardi&amp;rft.au=Sally%20Barrington&amp;rft.au=Peter%20W.%20M.%20Johnson&amp;rft.au=Maurizio%20Martelli&amp;rft.date=2023-06-10&amp;rft.pages=LBA7505-LBA7505&amp;rft.spage=LBA7505&amp;rft.epage=LBA7505&amp;rft.issn=0732-183X"></span>
</div>

